Orphan drug: Development trends and strategies
Aarti Sharma1, Abraham Jacob, Manas Tandon
1Drug Regulatory Affairs, Getwell Pharmaceuticals, Udyog Vihar, Gurgaon, India.
Journal of Pharmacy & Bioallied Sciences
|December 25, 2010
Summary
Pharmaceutical companies are shifting focus to orphan drugs due to patent expiries and generic competition. This strategy offers a path to market recovery and stability by addressing rare diseases.
Area of Science:
- Pharmacoeconomics
- Drug Development
- Regulatory Science
Background:
- The pharmaceutical industry faces slowed growth due to patent expirations, generic competition, and stringent regulations.
- Blockbuster drug exclusivity loss necessitates new business models for revenue stability.
- The shift towards orphan drugs represents a strategic pivot to mitigate financial impacts.
Purpose of the Study:
- To analyze global policies and incentives for orphan drug development.
- To identify challenges faced by pharmaceutical companies in the orphan drug sector.
- To examine recent advancements in orphan drug approvals and pipeline development.
Main Methods:
- Comparative analysis of international orphan drug policies.
- Review of regulatory support mechanisms (e.g., FDA, EU Commission).
- Assessment of current orphan drug pipeline and market trends.
Main Results:
- Orphan drugs present a viable business model to offset revenue loss from blockbuster patent expiries.
- Government incentives and regulatory support (e.g., special protocols) accelerate orphan drug development.
- The orphan drug sector shows promising growth in approvals, pipeline diversity, and future therapeutic potential.
Conclusions:
- Orphan drugs offer a key strategy for pharmaceutical industry recovery and market stability.
- The integrated healthcare solutions offered by orphan drugs foster innovation in therapeutics, diagnostics, and patient support.
- Despite challenges, the orphan drug market demonstrates significant potential for future growth and impact on rare disease treatment.
Related Concept Videos
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...